Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-14-000075

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Handelman Michael D · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-05-15 Grant or award : show line 1 in the form Stock Option (right to buy) +75,000 $7.95 2019-05-14 75,000 75,000 D
2014-05-15 Grant or award : show line 2 in the form Restricted Stock Units +75,000 $0.00 75,000 75,000 D
Loading xslF345X03/primary_doc.xml…